CIDRAP newsletters options
The US led the region in pertussis infections last year, with 28,783 confirmed and probable cases.
The number of reported US tuberculosis cases fell by 1% from 2024 to 2025, according to provisional data from the CDC.
In the past 30 days, H5N1 has been confirmed in 85 flocks, including 45 commercial and 40 backyard flocks.
The findings suggest that inflammation from infections requiring hospital care may speed the preclinical stage of dementia rather than initiate neurodegeneration.
Nearly 2,300 grants were abruptly terminated, eliminating roughly $2.5 billion in funding and disrupting thousands of scientific projects.
Research from Argentina suggests use of glyphosate may select for antibiotic-resistant bacteria in soil that could spread to hospitals.
About 90% of human H9N2 avian flu cases have been reported in China.
Federal law dictates the CDC must fill a Senate-confirmed position within 210 days of a vacancy.
Although the new vaccine fell short of its primary goal, it showed ‘clinically meaningful’ results in a secondary analysis.
Social and physical isolation were both tied to lower uptake of breast cancer and colorectal cancer screening, with physical isolation also tied to lower flu vaccine coverage.
The recent introduction of RSV vaccines has begged for a new understanding of RSV’s burden among older, community-dwelling adults.
There are currently 2 people in quarantine and none in isolation.
A review and meta-analysis of 19 studies involving 51 cystic fibrosis patients finds bacteriophage therapy was safe and well-tolerated, with improved lung function observed in 74% of patients.
More than 350,000 birds in Indiana have died from avian flu and response measures in March.
Researchers say the findings reveal an “underrecognized link between climate factors and antibiotic resistance.”
A joint report from the WHO and European health officials finds 79% of new TB cases are going undetected, which results in delayed treatment and more transmission of the disease.
The findings highlight how vulnerable US pharmaceutical manufacturing is to global supply chain problems.
BA.3.2 represents a new lineage of SARS-CoV-2, genetically distinct from the JN.1 lineages that have circulated in the US since January 2024.
Data show that young, healthy people have no additional risk of sudden death if they are vaccinated against COVID-19, contrary to myths that continue to circulate widely on social media.
About 18% of deaths in hospitalized children were related to sepsis, according to a new study.
